MedTrace Logo

A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis

NCT03333304 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2019-12-17

No results posted yet for this study

Summary

The aim of the study is to demonstrate if using one procalcitonin (PCT)-guided rule of stop of antimicrobials, the incidence of infections by C.difficile and by Multi-Drug-Resistant (MDR) bacteria during the next six months may be significantly decreased.

Conditions

Interventions

DIAGNOSTIC_TEST

Procalcitonin measurement

Discontinuation of antimicrobials according to Procalcitonin Kinetics

Sponsors & Collaborators

  • Hellenic Institute for the Study of Sepsis

    lead OTHER

Principal Investigators

  • Anastasia Antoniadou, MD, PhD · National Kapodistrian University of Athens, Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-24
Primary Completion
2019-01-20
Completion
2019-07-20

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03333304 on ClinicalTrials.gov